Skip to main content
Top
Published in: AIDS Research and Therapy 1/2022

Open Access 01-12-2022 | Meningitis | Research

A nomogram for predicting paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis among HIV-infected individuals in China

Authors: Xiaoxu Han, Hui Liu, Yuqi Wang, Peng Wang, Xin Wang, Yunyun Yi, Xin Li

Published in: AIDS Research and Therapy | Issue 1/2022

Login to get access

Abstract

Background

Cryptococcal meningitis (CM) associated immune reconstitution inflammatory syndrome (CM-IRIS) is the second most common complication in HIV-infected individuals with cryptococcal meningitis, with a reported mortality rate ranging from 8 to 30%. Given the devastating consequences of CM-IRIS related intracranial neuroinflammation and its challenging in diagnosis, we conducted a study to explore the risk factors and the occurrence of paradoxical CM-IRIS in HIV-infected patients, which is of great value for prevention and clinical management.

Methods

We conducted a retrospective cohort study to identify the indicators associated with paradoxical CM-IRIS among 86 HIV-infected patients with CM using univariate and multivariate cox analysis. A nomogram was constructed using selected variables to evaluate the occurrence of paradoxical CM-IRIS at 6 months and 12 months after ART initiation. The discrimination and calibration of the nomogram were assessed by concordance index (C-index) and calibration plots. Decision curves analysis (DCA) were used to evaluate clinical effectiveness of the nomogram. Subsequently, to help clinicians recognize patients at high risk faster, patients were divided into high-risk and low-risk groups according to the best cutoff point identified by X-tile.

Results

Of 86 AIDS patients with CM, 22.1% experienced paradoxical CM-IRIS at a median of 32 days after antiretroviral therapy (ART) initiation. The occurrence of paradoxical CM-IRIS was associated with age, ART initiation within 4 weeks of antifungal treatment, a four-fold increase in CD4 T cell counts, C-reactive protein levels, and hemoglobin levels independently. These five variables were further used to construct a predictive nomogram. The C-index (0.876) showed the favorable discriminative ability of the nomogram. The calibration plot revealed a high consistency between the predicted and actual observations. DCA showed that the nomogram was clinically useful. Risk stratification based on the total score of the nomogram showed well-differentiated in the high-risk and low-risk groups. Clinicians should pay attention to patients with total points high than 273.

Conclusions

We identified the predictive factors of paradoxical CM-IRIS and constructed a nomogram to evaluate the occurrence of paradoxical CM-IRIS in 6 months and 12 months. The nomogram represents satisfactory performance and might be applied clinically to the screening and management of high-risk patients.
Literature
1.
go back to reference Williamson P, Jarvis J, Panackal A, Fisher M, Molloy S, Loyse A, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017;13(1):13–24.CrossRef Williamson P, Jarvis J, Panackal A, Fisher M, Molloy S, Loyse A, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017;13(1):13–24.CrossRef
2.
go back to reference Ali A, Maaliki N, Oye M, Isache C. Cryptococcal meningitis presenting with acute hearing loss. BMJ Case Rep. 2021;14(5):e242059.CrossRef Ali A, Maaliki N, Oye M, Isache C. Cryptococcal meningitis presenting with acute hearing loss. BMJ Case Rep. 2021;14(5):e242059.CrossRef
3.
go back to reference Molloy S, Ross B, Kanyama C, Mfinanga S, Lesikari S, Heyderman R, et al. Fungal burden and raised intracranial pressure are independently associated with visual loss in human immunodeficiency virus-associated cryptococcal meningitis. Open Forum Infect Dis. 2021;8(4):ofab066.CrossRef Molloy S, Ross B, Kanyama C, Mfinanga S, Lesikari S, Heyderman R, et al. Fungal burden and raised intracranial pressure are independently associated with visual loss in human immunodeficiency virus-associated cryptococcal meningitis. Open Forum Infect Dis. 2021;8(4):ofab066.CrossRef
4.
go back to reference WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva: World Health Organization© World Health Organization 2018; 2018. WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva: World Health Organization© World Health Organization 2018; 2018.
5.
go back to reference Perfect J, Dismukes W, Dromer F, Goldman D, Graybill J, Hamill R, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291–322.CrossRef Perfect J, Dismukes W, Dromer F, Goldman D, Graybill J, Hamill R, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50(3):291–322.CrossRef
6.
go back to reference Masur H, Brooks J, Benson C, Holmes K, Pau A, Kaplan J. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the centers for disease control and prevention, national institutes of health, and HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;58(9):1308–11.CrossRef Masur H, Brooks J, Benson C, Holmes K, Pau A, Kaplan J. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the centers for disease control and prevention, national institutes of health, and HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2014;58(9):1308–11.CrossRef
7.
go back to reference French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis. 2009;48(1):101–7.CrossRef French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis. 2009;48(1):101–7.CrossRef
8.
go back to reference Wilson E, Sereti I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev. 2013;254(1):343–54.CrossRef Wilson E, Sereti I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev. 2013;254(1):343–54.CrossRef
9.
go back to reference Balasko A, Keynan Y. Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals. HIV Med. 2019;20(1):1–10.CrossRef Balasko A, Keynan Y. Shedding light on IRIS: from pathophysiology to treatment of cryptococcal meningitis and immune reconstitution inflammatory syndrome in HIV-infected individuals. HIV Med. 2019;20(1):1–10.CrossRef
10.
go back to reference Chang CC, Dorasamy AA, Gosnell BI, Elliott JH, Spelman T, Omarjee S, et al. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS. 2013;27(13):2089–99.CrossRef Chang CC, Dorasamy AA, Gosnell BI, Elliott JH, Spelman T, Omarjee S, et al. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS. 2013;27(13):2089–99.CrossRef
11.
go back to reference Yan S, Chen L, Wu W, Li Z, Fu Z, Zhang H, et al. Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study. Clin Microbiol Infec. 2015;21(4):379.e11-4.CrossRef Yan S, Chen L, Wu W, Li Z, Fu Z, Zhang H, et al. Paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis in China: a 5-year retrospective cohort study. Clin Microbiol Infec. 2015;21(4):379.e11-4.CrossRef
12.
go back to reference Sereti I, Sheikh V, Shaffer D, Phanuphak N, Gabriel E, Wang J, et al. Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people living with human immunodeficiency virus and severe lymphopenia. Clin Infect Dis. 2020;71(3):652–60.CrossRef Sereti I, Sheikh V, Shaffer D, Phanuphak N, Gabriel E, Wang J, et al. Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people living with human immunodeficiency virus and severe lymphopenia. Clin Infect Dis. 2020;71(3):652–60.CrossRef
13.
go back to reference Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol. 2017;19(5):669–77.PubMed Gittleman H, Lim D, Kattan MW, Chakravarti A, Gilbert MR, Lassman AB, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825. Neuro Oncol. 2017;19(5):669–77.PubMed
14.
go back to reference Li G, Chen JZ, Chen S, Lin SZ, Pan W, Meng ZW, et al. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma. Cancer Med. 2020;9(10):3353–70.CrossRef Li G, Chen JZ, Chen S, Lin SZ, Pan W, Meng ZW, et al. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma. Cancer Med. 2020;9(10):3353–70.CrossRef
15.
go back to reference Thao LTP, Heemskerk AD, Geskus RB, Mai NTH, Ha DTM, Chau TTH, et al. Prognostic models for 9-month mortality in tuberculous meningitis. Clin Infect Dis. 2018;66(4):523–32.CrossRef Thao LTP, Heemskerk AD, Geskus RB, Mai NTH, Ha DTM, Chau TTH, et al. Prognostic models for 9-month mortality in tuberculous meningitis. Clin Infect Dis. 2018;66(4):523–32.CrossRef
16.
go back to reference Wang P, Song W, Cheng S, Shuai Y, Yang J, Luo S. Establishment of a nomogram for predicting lumbar drainage-related meningitis: a simple tool to estimate the infection risk. Neurocrit Care. 2021;34(2):557–65.CrossRef Wang P, Song W, Cheng S, Shuai Y, Yang J, Luo S. Establishment of a nomogram for predicting lumbar drainage-related meningitis: a simple tool to estimate the infection risk. Neurocrit Care. 2021;34(2):557–65.CrossRef
17.
go back to reference Chinese center for disease control and prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018). Zhonghua Nei Ke Za Zhi. 2018. Chinese center for disease control and prevention. Chinese guidelines for diagnosis and treatment of HIV/AIDS (2018). Zhonghua Nei Ke Za Zhi. 2018.
18.
go back to reference Haddow L, Colebunders R, Meintjes G, Lawn S, Elliott J, Manabe Y, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791–802.CrossRef Haddow L, Colebunders R, Meintjes G, Lawn S, Elliott J, Manabe Y, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791–802.CrossRef
19.
go back to reference Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804.CrossRef Van Calster B, Wynants L, Verbeek JFM, Verbakel JY, Christodoulou E, Vickers AJ, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796–804.CrossRef
20.
go back to reference Camp R, Dolled-Filhart M, Rimm D. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–9.CrossRef Camp R, Dolled-Filhart M, Rimm D. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–9.CrossRef
21.
go back to reference Justice A. HIV and aging: time for a new paradigm. Curr HIV-AIDS Rep. 2010;7(2):69–76.CrossRef Justice A. HIV and aging: time for a new paradigm. Curr HIV-AIDS Rep. 2010;7(2):69–76.CrossRef
22.
go back to reference Dock J, Effros R. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis. 2011;2(5):382–97.PubMedPubMedCentral Dock J, Effros R. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis. 2011;2(5):382–97.PubMedPubMedCentral
23.
go back to reference Wu L, Xiao J, Song Y, Gao G, Zhao H. The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study. BMC Infect Dis. 2020;20(1):912.CrossRef Wu L, Xiao J, Song Y, Gao G, Zhao H. The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study. BMC Infect Dis. 2020;20(1):912.CrossRef
24.
go back to reference Eshun-Wilson I, Okwen M, Richardson M, Bicanic T. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. Cochrane Database of Syst Rev. 2018;7:CD009012. Eshun-Wilson I, Okwen M, Richardson M, Bicanic T. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis. Cochrane Database of Syst Rev. 2018;7:CD009012.
25.
go back to reference Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis. 2004;39(11):1709–12.CrossRef Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis. 2004;39(11):1709–12.CrossRef
26.
go back to reference Pirofski L, Casadevall A. Cryptococcus neoformansImmune-mediated damage completes the parabola: pathogenesis can reflect the outcome of a weak or strong immune response. eBio. 2017;8(6):e02063-17. Pirofski L, Casadevall A. Cryptococcus neoformansImmune-mediated damage completes the parabola: pathogenesis can reflect the outcome of a weak or strong immune response. eBio. 2017;8(6):e02063-17.
27.
go back to reference Jarvis J, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum J, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736–45.CrossRef Jarvis J, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum J, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58(5):736–45.CrossRef
28.
go back to reference Breglio K, Vinhaes C, Arriaga M, Nason M, Roby G, Adelsberger J, et al. Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with human immunodeficiency virus. J Infect Dis. 2021;223(12):2124–35.CrossRef Breglio K, Vinhaes C, Arriaga M, Nason M, Roby G, Adelsberger J, et al. Clinical and immunologic predictors of Mycobacterium avium complex immune reconstitution inflammatory syndrome in a contemporary cohort of patients with human immunodeficiency virus. J Infect Dis. 2021;223(12):2124–35.CrossRef
29.
go back to reference Vinhaes C, Sheikh V, Oliveira-de-Souza D, Wang J, Rupert A, Roby G, et al. An inflammatory composite score predicts mycobacterial immune reconstitution inflammatory syndrome in people with advanced HIV: a prospective international cohort study. J Infect Dis. 2021;223(7):1275–83.CrossRef Vinhaes C, Sheikh V, Oliveira-de-Souza D, Wang J, Rupert A, Roby G, et al. An inflammatory composite score predicts mycobacterial immune reconstitution inflammatory syndrome in people with advanced HIV: a prospective international cohort study. J Infect Dis. 2021;223(7):1275–83.CrossRef
30.
go back to reference Boras E, Slevin M, Alexander MY, Aljohi A, Gilmore W, Ashworth J, et al. Monomeric C-reactive protein and Notch-3 co-operatively increase angiogenesis through PI3K signalling pathway. Cytokine. 2014;69(2):165–79.CrossRef Boras E, Slevin M, Alexander MY, Aljohi A, Gilmore W, Ashworth J, et al. Monomeric C-reactive protein and Notch-3 co-operatively increase angiogenesis through PI3K signalling pathway. Cytokine. 2014;69(2):165–79.CrossRef
31.
go back to reference Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.CrossRef Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.CrossRef
32.
go back to reference Boulware D, Meya D, Bergemann T, Wiesner D, Rhein J, Musubire A, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7(12):e1000384.CrossRef Boulware D, Meya D, Bergemann T, Wiesner D, Rhein J, Musubire A, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7(12):e1000384.CrossRef
33.
go back to reference Stone S, Price P, Brochier J, French M. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis. 2001;184(8):1073–7.CrossRef Stone S, Price P, Brochier J, French M. Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy. J Infect Dis. 2001;184(8):1073–7.CrossRef
34.
go back to reference Narendran G, Andrade B, Porter B, Chandrasekhar C, Venkatesan P, Menon P, et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PloS ONE. 2013;8(5):e63541.CrossRef Narendran G, Andrade B, Porter B, Chandrasekhar C, Venkatesan P, Menon P, et al. Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction. PloS ONE. 2013;8(5):e63541.CrossRef
35.
go back to reference Dong Y, Sun J, Li Y, Chen Q, Liu Q, Sun Z, et al. Development and validation of a nomogram for assessing survival in patients with COVID-19 pneumonia. Clin Infect Dis. 2021;72(4):652–60.CrossRef Dong Y, Sun J, Li Y, Chen Q, Liu Q, Sun Z, et al. Development and validation of a nomogram for assessing survival in patients with COVID-19 pneumonia. Clin Infect Dis. 2021;72(4):652–60.CrossRef
Metadata
Title
A nomogram for predicting paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis among HIV-infected individuals in China
Authors
Xiaoxu Han
Hui Liu
Yuqi Wang
Peng Wang
Xin Wang
Yunyun Yi
Xin Li
Publication date
01-12-2022
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2022
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-022-00444-5

Other articles of this Issue 1/2022

AIDS Research and Therapy 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine